This patent teaches the use of skeletal myoblast, muscle stem cells, for treating urinary incontinence. The cells may be used without modification, or may be genetically engineered to express therapeutic genes. Examples of therapeutic genes include nerve growth factor, nitric oxide, etc.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.